Peptide Receptor Radionuclide Therapy (PRRT) with (177)Lu-DOTATATE; Differences in Tumor Dosimetry, Vascularity and Lesion Metrics in Pancreatic and Small Intestinal Neuroendocrine Neoplasms

SIMPLE SUMMARY: Patients suffering from disseminated, progressive, neuroendocrine neoplasms with a sufficient amount of somatostatin receptors and good kidney function can be treated with radioactive hormone-like molecules to prolong their life. In this study, the radioactivity in one tumor per pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Jahn, Ulrika, Ilan, Ezgi, Sandström, Mattias, Lubberink, Mark, Garske-Román, Ulrike, Sundin, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956792/
https://www.ncbi.nlm.nih.gov/pubmed/33668887
http://dx.doi.org/10.3390/cancers13050962

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956792/
https://www.ncbi.nlm.nih.gov/pubmed/33668887
http://dx.doi.org/10.3390/cancers13050962

Ejemplares similares